Biased signaling: A viable strategy to drug ghrelin receptors for the treatment of obesity
المؤلف | Karim, Nagi |
المؤلف | Habib, Abdella M. |
تاريخ الإتاحة | 2021-03-25T06:31:16Z |
تاريخ النشر | 2021-07-31 |
اسم المنشور | Cellular Signalling |
المعرّف | http://dx.doi.org/10.1016/j.cellsig.2021.109976 |
الاقتباس | Nagi K, Habib AM. Biased signaling: A viable strategy to drug ghrelin receptors for the treatment of obesity. Cell Signal. 2021 Mar 10;83:109976. doi: 10.1016/j.cellsig.2021.109976. |
الرقم المعياري الدولي للكتاب | 08986568 |
الملخص | Obesity is a global burden and a chronic ailment with damaging overall health effects. Ghrelin, an octanoylated 28 amino acid peptide hormone, is secreted from the oxyntic mucosa of the stomach. Ghrelin acts on regions of the hypothalamus to regulate feeding behavior and glucose homeostasis through its G protein-coupled receptor. Recently, several central pathways modulating the metabolic actions of ghrelin have been reported. While these signaling pathways can be inhibited or activated by antagonists or agonists, they can also be discriminatingly activated in a “biased” response to impart different degrees of activation in distinct pathways downstream of the receptor. Here, we review recent ghrelin biased signaling findings as well as characteristics of ghrelin hormone and its receptors pertinent for biased signaling. We then evaluate the feasibility for ghrelin receptor biased signaling as a strategy for the development of effective pharmacotherapy in obesity treatment. |
اللغة | en |
الناشر | Elsevier |
الموضوع | Bias Ghrelin Biased agonism Obesity Dimer Functional selectivity |
النوع | Article |
رقم المجلد | 83 |
Open Access user License | http://creativecommons.org/licenses/by/4.0/ |
تحقق من خيارات الوصول
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
أبحاث الطب [1418 items ]